The Portfolio returned 7.33% gross, significantly outperforming the MSCI World Health Care Index's 3.12% return. Click here ...

For a stock that had been struggling for significance for much of the past year, this dramatic shift was not merely a rally — ...

REGAL is a Phase 3 randomized study testing GPS in AML patients who reached complete remission after a second round of rescue ...

Through the first three quarters of 2025, M&A activity overtook the entire 2024 total, according to Endpoints News. Editor and founder John Carroll wrote in October this might be the best time in 15 ...

The average one-year price target for Wave Life Sciences (NasdaqGM:WVE) has been revised to $32.70 / share. This is an increase of 60.82% from the prior estimate of $20.34 dated December 3, 2025. The ...

Life Sciences ventures face high levels of scientific, clinical and commercial pathway uncertainty, and these uncertainties present many opportunities for entrepreneurial innovation. This course is ...

The developer behind Philadelphia's largest life sciences building says the market needs patience after venture capital ...

Salesforce (NYSE: CRM), the world’s #1 AI CRM, announced today that Novartis (NYSE: NVS), a leading global innovative ...

The 2024-25 Sustainability Report reflects the company’s long-term view-one that places science, responsibility, and ...

The Board on Life Sciences (BLS) was established in 1984 to serve as the focal point for addressing critical, emerging policy and technical issues associated with the life sciences and biotechnology ...

William “Bill” McKeon is the President and Chief Executive Officer of the Texas Medical Center. He is responsible for driving strategic, operational and programmatic initiatives across the Texas ...

Zorawar Singh ji, then aged about eight years, and Fateh Singh ji, about six years old, were executed by Wazir Khan, the ...